The cannabis plant is famous mostly for producing THC, the compound responsible for cannabis’s psychotropic high, and cannabidiol (CBD), the primary non-psychoactive agent in the cannabis plant. CBD has earned a name for itself over the years as a versatile, efficient solution to a variety of medical conditions. People with conditions like anxiety, insomnia, chronic pain, and a host of other mild and severe conditions have reported impressive results after using CBD.
Despite this, cannabidiol remains mostly unregulated, and this has left the industry in a state of lawlessness, with sellers making unsubstantiated claims and selling products with different levels of CBD than what was advertised. The CBD sector has even been referred to as the ‘Wild West’ with some producers selling products whose quality is…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor